People aren’t dumb. Even if — or maybe especially if — news stories don’t point out the limitations of observational studies and the fact that they can’t establish cause-and-effect, many readers seem to get it.
* “I love how an article starts with something positive and then slowly becomes a little gloomy. So is it good or not? I’m still where I was with coffee, it’s all in moderation, it ain’t gonna solve your health woes.”
* “The statistics book in a class I’m taking uses coffee as an example of statistics run amuck. It seems coffee has caused all the cancers and cures them at the same time.”Read more »
Headlines every day in the New York Daily News are luring men in as part of a mass prostate cancer screening campaign that the American Cancer Society not only does not endorse, but its chief medical officer recommends against. Yet the paper brags that it’s beginning its second decade of this non-evidence-based campaign. Sample headlines:
• Doctors urge New York men to take advantage of free, city-wide PSA testing
• What you don’t know can kill you. Get a FREE prostate cancer test. It can save your life
• Bring dad in for FREE prostate cancer test across the city on Father’s Day
and
• Don’t skip the PSA test! My prostate cancer is treatable because simple test caught it early (written by a Daily News staffer). Read more »
A German physician wrote me about this, so while CNN may have an international reach, it’s not always with an adoring audience.
The physician was reacting to the weekend “Paging Dr. Gupta” program, which Dr. Gupta referred to once as “SG, MD.” The first thing that struck me was his introduction, in which he said:
“I’m your doctor. I’m also your coach.”
Later in the program he said:
“Think of this as your appointment. No waiting. No insurance necessary.”
I find this very troubling. He’s not my doctor. He’s not my coach. When I watch a “news” program, it’s NOT my medical appointment. It’s supposed to be news, not medical advice.
But that’s not what the German physician wrote to me about, so I kept watching (the segment in question appears about 5 minutes and 30 seconds deep, and after the 30-second commercial you have to watch to get there):
Gupta reacted to a viewer’s message on Twitter in which the tweep asked: “Does anyone know a ‘miracle’ treatment for ovarian cancer?” Read more »
This week the FDA will vote on flibanserin, the much-talked-about drug for women with the condition called hypoactive sexual desire disorder or — because everything in sexual health needs an acronym like ED or PE — HSDD.
On the eve of the FDA vote, CBS last week ran still another story about flibanserin. This drug has received so much news coverage, you’d think it cures cancer.
And CBS did little more than promote the hype even more, saying FDA approval “could translate into a $2 billion market in this country alone” and then failing to challenge the disease-mongering estimate of “10 percent to 30 percent of women” with this condition. It all just goes along with the drug company’s efforts to build a demand before the drug is even approved. Read more »
In recent days, news readers/viewers/listeners have been bombarded with news from the big American Society of Clinical Oncology conference in Chicago. But how does some of this stuff become news? Read an excellent post by an excellent reporter, Ron Winslow of the Wall Street Journal, to see some of the crazy, ugly sausage-making that goes on in the manipulation of the media. In the example Winslow raises, what may be packaged as news really isn’t “new” — which is often the case.
It’s no secret that doctors are disappointed with the way that the U.S. healthcare system is evolving. Most feel helpless about improving their work conditions or solving technical problems in patient care. Fortunately one young medical student was undeterred by the mountain of disappointment carried by his senior clinician mentors…
I am proud to be a part of the American Resident Project an initiative that promotes the writing of medical students residents and new physicians as they explore ideas for transforming American health care delivery. I recently had the opportunity to interview three of the writing fellows about how to…
I m often asked to do book reviews on my blog and I rarely agree to them. This is because it takes me a long time to read a book and then if I don t enjoy it I figure the author would rather me remain silent than publish my…
When I was in medical school I read Samuel Shem s House Of God as a right of passage. At the time I found it to be a cynical yet eerily accurate portrayal of the underbelly of academic medicine. I gained comfort from its gallows humor and it made me…
I am hesitant to review diet books because they are so often a tangled mess of fact and fiction. Teasing out their truth from falsehood is about as exhausting as delousing a long-haired elementary school student. However after being approached by the authors’ PR agency with the promise of a…
This week the FDA will vote on flibanserin, the much-talked-about drug for women with the condition called hypoactive sexual desire disorder or — because everything in sexual health needs an acronym like ED or PE — HSDD.
